Jamieson Wellness Inc. Announces Voting Results from 2021 Annual and Special Meeting of Shareholders Pharmaceutical Investing
Organon Set to Join S&P 500; HollyFrontier to Join S&P MidCap 400; Service Properties Trust to Join S&P SmallCap 600 Pharmaceutical Investing
U.S. Food and Drug Administration Approves Bristol Myers Squibb's Zeposia® , an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis1 Biotech Investing
Knight Therapeutics Announces Closing of Previously Announced Acquisition and Exclusive License to Exelon® in Canada and Latin America Medical Device Investing
Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids Pharmaceutical Investing
AbbVie to Present Data from its Leading Migraine Portfolio at the 2021 American Headache Society Annual Scientific Meeting Biotech Investing
Bristol Myers Squibb to Take Part in Bernstein's 37th Annual Strategic Decisions Conference Biotech Investing
Satcher Health Leadership Institute At Morehouse School Of Medicine, With Support From Google.org And Gilead Sciences, Launches Health Equity Tracker To Study Racial Health Inequities Related To Covid-19 Biotech Investing
